In Situ Hybridization Market: Trends, Opportunities and Competitive Analysis [2023-2028]

In Situ Hybridization Market Trends and Forecast

The future of the in situ hybridization market looks promising with opportunities in the research & diagnostic laboratory, CRO, and academic institute end use industries. The global in situ hybridization market is expected to reach an estimated $2.4 billion by 2028 with a CAGR of 9.4% from 2023 to 2028. The major drivers for this market are increasing prevalence of genetic diseases, rising awareness towards cancer therapeutics, and growing government initiatives.

In Situ Hybridization Market by Technology, Probe, Product, Application, End Use Industry, and Region

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

In Situ Hybridization Market by Segments

In Situ Hybridization Market by Segment

The study includes trends and forecast for the global in situ hybridization market by technology, probe, product, application, end use industry, and region, as follows:

In Situ Hybridization Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:

Fluorescent In Situ Hybridization (FISH)

Chromogenic In Situ Hybridization (CISH)

In Situ Hybridization Market by Probe [Value ($B) Shipment Analysis from 2017 to 2028]:

DNA

RNA

In Situ Hybridization Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

Instruments

Kits & Probes

Software

Services

In Situ Hybridization Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

Cancer

Cytogenetics

Developmental Biology

Infectious Diseases

Others

In Situ Hybridization Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

Research & Diagnostic Laboratories

CROs

Academic Institutes

Others

In Situ Hybridization Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of In Situ Hybridization Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, in-situ hybridization companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-situ hybridization companies profiled in this report include-

Thermo Fisher Scientific

Abbott

PerkinElmer

BioView

Agilent Technologies

In Situ Hybridization Market Insights

Lucintel forecasts that FISH will remain the larger technology segment over the forecast period because it provides researchers with a method to visualize and map the genetic components in a single cell.

Research & diagnostic laboratories are expected to remain the largest segment due to the rising requirement for rapid & accurate diagnostic techniques.

North America will remain the largest region due to availability of technologically upgraded infrastructure, increasing prevalence of infectious diseases, and growing demand for early diagnosis of diseases in the region.

Features of the In Situ Hybridization Market

Market Size Estimates: In situ hybridization market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: In situ hybridization market size by various segments, such as technology, probe, product, application, end use industry, and region

Regional Analysis: In situ hybridization market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different technology, probes, products, applications, end use industries, and regions for the in situ hybridization market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the in situ hybridization market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the in situ hybridization market size?

Answer: The global in situ hybridization market is expected to reach an estimated $2.4 billion by 2028.

Q2. What is the growth forecast for in situ hybridization market?

Answer: The global in situ hybridization market is expected to grow with a CAGR of 9.4% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the in situ hybridization market?

Answer: The major drivers for this market are increasing prevalence of genetic diseases, rising awareness towards cancer therapeutics, and growing government initiatives.

Q4. What are the major segments for in situ hybridization market?

Answer: The future of the in situ hybridization market looks promising with opportunities in the research & diagnostic laboratory, CRO, and academic institute end use industry.

Q5. Who are the key in situ hybridization companies?

Answer: Some of the key in situ hybridization companies are as follows:

Thermo Fisher Scientific

Abbott

PerkinElmer

BioView

Agilent Technologies

Q6. Which in situ hybridization segment will be the largest in future?

Answer: Lucintel forecasts that FISH will remain the larger technology segment over the forecast period because it provides researchers with a method to visualise and map the genetic components in a single cell.

Q7. In in situ hybridization market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to availability of technologically upgraded infrastructure, increasing prevalence of infectious diseases, and growing demand for early diagnosis of diseases in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

• Q.1. What are some of the most promising, high-growth opportunities for the in situ hybridization market by technology (fluorescent in situ hybridization (FISH) and chromogenic in situ hybridization (CISH)), probe (DNA and RNA), product (instruments, kits & probes, software, and services), application (cancer, cytogenetics, developmental biology, infectious diseases, and others), end use industry (research & diagnostic laboratories, CROs, academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?